Prevalence and Genotype Distribution of Human Papillomavirus Infection among 12 076 Iranian Women

被引:22
作者
Bitarafan, Fatemeh [1 ]
Hekmat, Mohammad Reza [1 ]
Khodaeian, Mehrnoosh [1 ]
Razmara, Ehsan [2 ]
Ashrafganjoei, Tahereh [3 ]
Gilani, Mitra Modares [4 ]
Mohit, Mitra [5 ]
Aminimoghaddam, Soheila [6 ]
Cheraghi, Fatemeh [7 ]
Khalesi, Raziyeh [1 ]
Rajabzadeh, Parnian [1 ]
Sarmadi, Soheila [8 ]
Garshasbi, Masoud [2 ]
机构
[1] Dept Med Genet, Dena Lab, Tehran, Iran
[2] Tarbiat Modares Univ, Dept Med Genet, Fac Med Sci, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Imam Hosein Hosp, Tehran, Iran
[4] Univ Tehran Med Sci, Tehran, Iran
[5] Islamic Azad Univ, Tehran Med Branch, Dept Obstet & Gynecol, Fac Med, Tehran, Iran
[6] Iran Univ Med Sci, Tehran, Iran
[7] Erfan Hosp, Tehran, Iran
[8] Univ Tehran Med Sci, Sch Med, Dept Pathol, Tehran, Iran
关键词
Cervical cancer; Human papillomavirus; Iranian population; Genotype distribution; CERVICAL-CANCER; INTRAEPITHELIAL NEOPLASIA; HPV VACCINATION; LESIONS;
D O I
10.1016/j.ijid.2021.07.071
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Human papillomavirus (HPV) infection is one of the major health concerns of women in developing countries. This study gives an insight into the prevalence and genotype distribution of HPV infection and compares it with Pap smear results among Iranian women. Methods: In this study, 12 076 Iranian women underwent routine examination from November 2016 to November 2018 using HPV Direct Flow CHIP System for HPV DNA typing. Cytology was undertaken for 5138 samples. Results: Overall HPV prevalence was calculated at 38.68%. The most frequent HPV types were HPV 6, 16, 11, 62/81, 52 and 54. The most high-risk HPV (HR-HPV) types were HPV 16, 52, 18, 39, 31 and 51. These 2 groups represent approximately half of all HPV types detected, 47% and 55%, respectively. Among individuals who underwent cytological tests, 135 individuals (2.63%) were cytologically positive. In this group, 81 individuals (60%) were HPV positive, 62 (76%) of whom were HR-HPV positive, most frequently with HPV 16 (34%). Conclusion: This study highlights the urgent need for public education and early diagnosis using HPV screening tests to prevent cervical cancer. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:295 / 302
页数:8
相关论文
共 39 条
[1]  
Ahmadi M, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0019
[2]   Human papillomavirus genotyping and integration in ovarian cancer Saudi patients [J].
Al-Shabanah, Othman A. ;
Hafez, Mohamed M. ;
Hassan, Zeinab K. ;
Sayed-Ahmed, Mohamed M. ;
Abozeed, Waleed N. ;
Al-Rejaie, Salem S. ;
Alsheikh, Abdulmalik A. .
VIROLOGY JOURNAL, 2013, 10
[3]   Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices [J].
Blatt, Amy J. ;
Kennedy, Ronald ;
Luff, Ronald D. ;
Austin, R. Marshall ;
Rabin, Douglas S. .
CANCER CYTOPATHOLOGY, 2015, 123 (05) :282-288
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]   HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives [J].
Castellsague, Xavier ;
Schneider, Achim ;
Kaufmann, Andreas M. ;
Xavier Bosch, F. .
GYNECOLOGIC ONCOLOGY, 2009, 115 (03) :S15-S23
[6]   Genotype distribution and the relative risk factors for human papillomavirus in Urumqi, China [J].
Chen, Zhifang ;
Meng, Wei ;
Du, Rong ;
Zhu, Yuejie ;
Zhang, Yi ;
Ding, Yan .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (01) :85-90
[7]   DNA ploidy measurement and human papillomavirus in abnormal cervical cytology [J].
Costa, Ane Francyne ;
Pogere, Adriane ;
Beltrame Farina Pasinato, Ana Paula ;
Monteiro Bello, Edson Jose ;
Casimiro Onofre, Alexandre Sherlley ;
de Miranda Onofre, Fabiana Botelho .
CYTOPATHOLOGY, 2021, 32 (02) :180-186
[8]   HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran [J].
Esmaeili, Mohsen ;
Bonyadi, Mortaza ;
Dastranj, Ali ;
Alizadeh, Masoumeh ;
Melli, Manizheh Sayyah ;
Shobeiri, Mehri Jafari .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2008, 66 (01) :68-72
[9]  
Hamkar R, 2002, East Mediterr Health J, V8, P805
[10]   Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age [J].
Harper, Diane M. .
GYNECOLOGIC ONCOLOGY, 2008, 110 (03) :S11-S17